Richard S. Lindahl

Insider Reports History

Entity
Individual
Location
Nextel, 2001 Edmund Halley Dr, Reston, Virginia
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard S. Lindahl:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. EVP, Chief Financial Officer Common Stock 156K $966K $6.19 Jun 8, 2024 Direct
Emergent BioSolutions Inc. EVP, Chief Financial Officer Employee Stock Options (Right to Buy) 306K Mar 13, 2024 Direct
Emergent BioSolutions Inc. EVP, Chief Financial Officer Employee Stock Option (Right to buy) 181K Jun 9, 2023 Direct
Compass Therapeutics, Inc. Director Stock Option (Right to Buy) 40K Feb 9, 2024 Direct

Insider Reports Filed by Richard S. Lindahl

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EBS Emergent BioSolutions Inc. Jun 8, 2024 1 -$16.9K 4 Jun 11, 2024 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. Mar 13, 2024 1 $0 4 Mar 15, 2024 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. Feb 29, 2024 2 -$31.5K 4 Mar 4, 2024 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. Feb 21, 2024 2 -$12.3K 4 Feb 27, 2024 EVP, Chief Financial Officer
CMPX Compass Therapeutics, Inc. Feb 9, 2024 1 $0 4 Feb 14, 2024 Director
EBS Emergent BioSolutions Inc. Jun 9, 2023 3 $0 4 Jun 13, 2023 EVP, Chief Financial Officer
CMPX Compass Therapeutics, Inc. Apr 21, 2023 1 $0 4 Apr 24, 2023 Director
CMPX Compass Therapeutics, Inc. Apr 21, 2023 0 $0 3 Apr 24, 2023 Director
EBS Emergent BioSolutions Inc. Mar 2, 2023 3 $0 4 Mar 6, 2023 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. Feb 28, 2023 1 -$13.3K 4 Mar 2, 2023 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. Feb 23, 2023 2 -$19.7K 4 Feb 27, 2023 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. Feb 8, 2023 2 -$31.7K 4 Feb 10, 2023 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. Feb 28, 2022 4 $1.57M 4 Mar 2, 2022 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. Feb 23, 2022 2 -$63.5K 4 Feb 25, 2022 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. Feb 22, 2022 2 -$97K 4 Feb 24, 2022 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. Nov 15, 2021 1 $112K 4 Nov 15, 2021 EVP, Chief Financial Officer
EBS Emergent BioSolutions Inc. May 8, 2021 1 -$64.9K 4 May 11, 2021 EVP, Chief Financial Officer